drugset / Trial / NCT00737841

Effect of Bifidobacterium on Irritable Bowel Syndrome

NCT00737841

Unknown 50 enrolled Tohoku University
RandomizedParallel-groupQuadruple-blindBasic science

Summary

There has been no data on effect of Bifidobacterium breve on symptoms of patients with irritable bowel syndrome (IBS). We hypothesized that Bifidobacterium breve is effective on symptoms of IBS patients.

Timeline

Start
2006-01
Primary completion
2008-08
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium breve Other / unclassified 1 g Oral